Cholangiocarcinoma risk factors and the potential role of aspirin
Fabio Bagante, T. Clark Gamblin, Timothy M. Pawlik – 26 April 2016
Editorial Board
26 April 2016
Reply
Natasha K. Martin, Peter Vickerman, Matthew Hickman – 26 April 2016
Patient‐derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management
Delphine Nicolle, Monique Fabre, Marina Simon‐Coma, Aurore Gorse, Roland Kappler, Lara Nonell, Mar Mallo, Hazar Haidar, Olivier Déas, Charlotte Mussini, Catherine Guettier, Marie‐José Redon, Laurence Brugières, Maria Rosa Ghigna, Elie Fadel, Louise Galmiche‐Rolland, Christophe Chardot, Jean‐Gabriel Judde, Carolina Armengol, Sophie Branchereau, Stefano Cairo – 26 April 2016 – Identification of new treatments for relapsing pediatric cancer is an unmet clinical need and a societal challenge.
Reply
Veronica Miller, Patrick Harrington, Anita Howe, Tara Kieffer, Johan Lennerstrand, Oliver Lenz, Erik Lontok, Fiona McPhee, Hongmei Mo, Neil Parkin, Tami Pilot‐Matias – 26 April 2016
The effect of cirrhosis on radiogenomic biomarker's ability to predict microvascular invasion and outcome in hepatocellular carcinoma
Haiyun Tang, Harrison X. Bai, Chang Su, Ashley M. Lee, Li Yang – 26 April 2016
Cholangiocarcinoma risk factors and the potential role of aspirin
Fabio Bagante, T. Clark Gamblin, Timothy M. Pawlik – 26 April 2016